Striatal inhomogeneities and basal ganglia function

Movement Disorders

Volumn 1, Issue 1, 1986, Pages 3-15

  Penney, John B ^a   Young, Anne B ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; DOPAMINE RECEPTOR; RECEPTORS, GABA A;

BASAL GANGLION; CORPUS STRIATUM; DRUG EFFECT; HISTOLOGY; HUMAN; MOTOR DYSFUNCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SUBSTANTIA NIGRA;

BASAL GANGLIA; CORPUS STRIATUM; HUMAN; MOVEMENT DISORDERS; RECEPTORS, DOPAMINE; RECEPTORS, GABA-A; SUBSTANTIA NIGRA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0022939250     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.870010102     Document Type: Review

References (91)

1. The pathophysiology of movement disorders
2. Huntington's disease: a decade of progress
3. Huntington disease in Venezuela: neurological features and functional decline
4. Anatomy of the corpus striatum and brainstem integrating systems
5. Neurochemically specified subsystems in the basal ganglia
6. Biochemical anatomy of the striatum
7. Neurochemical anatomy of movement disorders
8. Effect of frontal cortex ablation on striatal glutamic acid level in rat
9. Glutamatergic corticostriatal path?
10. Decreased glutamate uptake in subcortical areas deafferented by sensorimotor cortical ablation in the cat
11. Distribution of glutamate decarboxylase, choline acetyltransferase and aromatic amino acid decarboxylase in the basal ganglia of normal and operated rats. Evidence for striatopallidal, striatoentopeduncular and striatonigral GABAergic fibres
12. Anterior striatal projections to the globus pallidus, entopeduncular nucleus and substantia nigra in the rat: The GABA connection
13. Recurrent inhibition in the rat neostriatum
14. Medium spiny neuron projection from the rat striatum: an intracellular horseradish peroxidase study
15. Morphological and physiological properties of neostriatal neurons: an intracellular horseradish peroxidase study in the rat
16. Immunocytochemical localization of choline acetyltransferase within the rat neostriatum: a correlated light and electron microscopic study of cholinergic neurons and synapses
17. Ultrastructural features of immunoreactive somatostatin neurons in the rat caudate nucleus
18. Striatal neurons containing both somatostatin and avian pancreatic polypeptide (APP) like immunoreactivity and NADPH‐diaphorase activity: a light and electron microscopic study
19. Survival of basal ganglia neuropeptide Y‐somatostatin neurons in Huntington's disease
20. Speculations on the functional anatomy of basal ganglia disorders
21. Evidence for a GABA‐ergic projection from the substantia nigra to the ventromedial thalamus and to the superior colliculus of the rat
22. Evidence for a GABAergic nigrothalamic pathway in the rat. I. Behavioural and biochemical studies
23. GABA as the pallidothalamic neurotransmitter: Implications for basal ganglia function
24. Cortical inputs to the subthalamus: intracellular analysis
25. The afferent and efferent connections of the ventromedial thalamic nucleus in the rat
26. Organization of the nigrothalamocortical system in the rhesus monkey
27. The origin of thalamic inputs to the arcuate premotor and supplementary motor areas
28. Differential activation of the two types of pyramidal tract neurons through the cerebellothalamocortical pathway
29. 3H]aspartate in thalamocortical neurons
30. Eye movement disorders in basal ganglia disease
31. Evidence for the existence of monoamine‐containing neurons in the central nervous system
32. Stereotaxic mapping of the monamine pathways in the rat brain
33. Simpler networks
34. Disinhibition as a basic process in the expression of strial functions. I. The striato‐nigral influence on tecto‐spinal/tecto‐diencephalic neurons
35. Disinhibition as a basic process in the expression of striatal functions. II. The striato‐nigral influence on thalamocortical cells of the ventromedial thalamic nucleus
36. γ‐Aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6‐hydroxydopamine lesions of the medial forebrain bundle
37. The GABA receptor and animal behavior
38. Metabolic effects of unilateral lesion of the substantia nigra
39. Effects of dopamine stimulation on functional brain metabolism in rats with unilateral substantia nigra lesions
40. Motor functions of the basal ganglia
41. The internal organization of the mouse caudate nucleus: evidence for cell clustering and regional variations
42. Histochemically distinct compartments in the striatum of human, monkey and cat demonstrated by acetylcholinesterase staining
43. Studies on different types of dopamine nerve terminals in the forebrain and their possible interactions with hormones and with neurons containing GABA, glutamate, and opioid peptides
44. The relation of striosomes in the caudate nucleus of the cat to the organization of early‐developing dopaminergic fibres, GAD‐positive neurophil, and CAT‐positive neurons
45. 3H]thymidine neuronography and histochemical staining
46. Localization of calcium binding protein in striatonigral and nigrostriatal systems in the rat and monkey
47. The dopamine‐containing innervation of striosomes: nigral subsystems and their striatal correspondents
48. The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systems
49. The neostriatal mosaic. I. Compartmental organization of projectios from the striatum to the substantia nigra in the rat
50. Multiple patterns of corticostriatal projections and their relationship to opiate receptor patches in rats
51. Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey
52. The fronto‐striatal projection in the cat and monkey and its relationship to inhomogeneities established by acetylcholinesterase histochemistry
53. Cytoarchitectonic heterogeneity of the primate neostriatem: subdivision into island and matrix cellular compartments
54. Mosaic distribution of opiate receptors, parafascicular projections and acetylcholinesterase in rat striatum
55. Distribution of cell bodies expressing substance P, enkephalin and dynorphin B in kitten and cat striatum
56. Mosaic distribution of neurotensin‐like immunoreactivity in the cat striatum
57. An immunohistochemical study of enkephalins and other neuropeptides in the striatum of the cat with evidence that the opiate peptides are arranged to form mosaic patterns in register with the striosomal compartments visible by acetylcholinesterase staining
58. The influence of neostriatal patch and matrix compartments on the dendritic geometry of spiny projection neurons in the rat as revealed by intracellular labeling with HRP combined with immunocytochemistry
59. Radioautographic quantification of the dopamine innervation in adult rat neostriatum
60. The GABA neurons and their axon terminals in rat corpus striatum as demonstrated by GAD immunohistochemistry
61. The striatopallidal and striatonigral projections: two distinct fiber systems in primate
62. Electrophysiology of the corpus striatum and brain stem integrating systems
63. Selective sparing of a class of striatal neurons in Huntington's disease
64. Inhibitory influence of the nigrostriatal dopamine system on the striatal cholinergic neurons in the rat
65. 2‐dopamine receptors in rat neostriatum inhibits the release of acetylcholine and dopamine but does not affect the release of γ‐aminobutyric acid, glutamate or serotonin
66. Opioid peptide‐like immunoreactivity localized in GABAergic neurons of rat neostriatum and central amygdaloid nucleus
67. Glutamic acid decarboxylase, leucine‐enkephalin and substance‐P immunoreactive neurons in the neostriatum of the rat and cat
68. Localization of immunoreactive enkephalins in GABA synthesizing neuron of the rat striatum
69. Evidence for a long term leu‐enkephalin striato‐palliadal pathway in rat brain
70. Correlation between met‐enkephalin and substance P immunoreactivity in the primate globus pallidus
71. The comparative distribution of enkephalin, dynorphin and substance P in the human globus and basal forebrain
72. Topographical projections of substance P and GABA pathways in the striatal pallido‐nigral system: a biochemical and immunohistochemical study
73. Dynorphin immunoreactivity in rat and guinea‐pig nervous system
74. Comparison of the distribution of dynorphin systems and enkephalin systems in brain
75. Parkinson's disease: depletion of substantia nigra neurotensin receptors
76. Intracellular study of rat substantia nigra pars reticulata neurons in in vitro slice preparation: electrical membrane properties and response characteristics to subthalamic stimulation
77. Alterations in postmortem brain angiotensin‐converting enzyme activity and some neuropeptides in Huntington's disease
78. Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia
79. Neuropathological classification of Huntington's disease
80. Caudate efferents in perinatal rats originate primarily from patches receiving dopaminergic input
81. Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine
82. Turnover times of gamma‐aminobutyric acid and acetylcholine in nucleus caudatus, nucleus accumbens, globus pallidus and substantia nigra: effects of repeated administration of haloperidol
83. Pharmacology of Parkinson's disease
84. The ergolene derivative MPME induces in the rat a behavioural syndrome associated with activation of dopamine D‐1 receptors belonging to the dotted type of forebrain dopamine nerve terminals
85. Huntington's disease: overview of experimental therapeutics
86. THIP treatment of Huntington's disease
87. Opioid responsiveness of neuroleptic induced akathisia